Dr Arnab Basu, chief executive of Kromek Group PLC (LON:KMK) tells Proactive's Andrew Scott the use of their radiation technology at high profile political events - such as US President Donald Trump's visit to Brussels - validates their business model.

Kromek was informed that the deployment was successful and its radiation detection systems performed well and met the desired high standards for accuracy and efficiency.

"I am keen to use my international experience to support the management team objective of achieving full commercial value for its impressive radiation detection technology," said new board member, Christopher WIlks

Kromek Group plc is a leading developer of radiation detection solutions based on high performance sensor materials, primarily cadmium zinc telluride (CZT), for applications within the medical, nuclear and security screening markets. Our solutions provide high resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials (including explosives), and the analysis of radioactive materials.
With our vertically integrated technology offering and IP portfolio of over 247 patents, Kromek provides an end-to-end solution from the growth of CZT crystals to the design, development and manufacturing of finished products, including software, electronics and ASICs.

Partners:

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for
listed tech companies to interact with
institutional and highly capitalised investors. Headquartered in London, Tech Capital is led by a team of Europe's
leading analysts and journalists, publishing daily content, covering all key movements
in the Technology market.